Study Identifies Metabolic-Cytoskeletal Axis Controlling Hematopoietic Stem Cell Function During Culture
Researchers used ultra-low input proteomics and 3D super-resolution imaging to map how human hematopoietic stem cells (HSCs) change at the protein and structural level during ex vivo expansion. The study identified a previously unrecognized metabolic-cytoskeletal axis that drives organelle reorganization and loss of structural polarity in cultured HSCs. The findings suggest that cell growth and functional deterioration are separable processes, potentially opening new avenues for improving stem cell therapies.
A new preprint study published on bioRxiv investigated why hematopoietic stem cells (HSCs) — the cells responsible for producing all blood and immune cells — lose functional integrity when grown outside the body, a major obstacle for transplantation and gene therapies. Using a scalable ultra-low input proteomics pipeline combined with 3D super-resolution imaging, researchers mapped the proteomic and spatial organization of primary human HSCs as they adapted to ex vivo culture conditions. The analysis uncovered a metabolic-cytoskeletal axis that coordinates organelle reorganization and structural polarity during this adaptation process, a mechanism that had been invisible to prior transcriptional (RNA-level) studies. Crucially, when researchers perturbed this axis, they were able to preserve structural polarity in HSCs while decoupling it from biomass expansion, demonstrating that growth and functional decline are not inherently linked. This challenges a longstanding assumption that expansion of HSCs in culture necessarily compromises their function. The findings provide a new conceptual framework for understanding ex vivo HSC adaptation and could guide the rational design of next-generation cellular therapies with improved clinical outcomes.
What's missing
As a preprint, this study has not yet undergone peer review, and its findings should be interpreted with caution. The study does not report whether preserving structural polarity via perturbation of the metabolic-cytoskeletal axis translates into improved functional outcomes in animal models or clinical settings.
What different sources said
- bioRxivCenter
Spatiotemporal Proteome Remodeling Directs Human Hematopoietic Stem Cells via a Metabolic-Cytoskeletal Axis
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.